annb0t
Top 20
Melbourne, Victoria --News Direct-- Recce Pharmaceuticals Ltd
Recce Pharmaceuticals Ltd (ASX:RCE) CEO James Graham tells Proactive that the company has been given a boost from the Australian Patent Office, which has issued notification of âintent to grantâ for the first of Recceâs new Patent Family 4 anti-infectives. The patent covers the 'Process for Preparation of Biologically Active Copolymer' and expires in 2041.
Contact Details
Proactive Investors
Jonathan Jackson
+61 41...
>>> Read more: Recce Pharmaceuticals further strengthens market monopoly for anti-infectives
Recce Pharmaceuticals Ltd (ASX:RCE) CEO James Graham tells Proactive that the company has been given a boost from the Australian Patent Office, which has issued notification of âintent to grantâ for the first of Recceâs new Patent Family 4 anti-infectives. The patent covers the 'Process for Preparation of Biologically Active Copolymer' and expires in 2041.
Contact Details
Proactive Investors
Jonathan Jackson
+61 41...
>>> Read more: Recce Pharmaceuticals further strengthens market monopoly for anti-infectives
